-
PROVIDERS
Register now
Are you getting the full picture? A webinar series on the power of comprehensive intelligent diagnostics
-
LIFE SCIENCES
Register now
AI & ML in action: Innovations in clinical trial enrollment
Thursday, April 10, 2025
12 PM PT / 2 PM CT / 3 PM ET -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Liquid biopsy and CDx in pancreatic cancer
Mike Yasiejko, General Manager and Executive Vice President at Tempus, recently spoke with Andrew Mazar, PhD, Chief Operating Officer at Actuate Therapeutics, about the ways Tempus’ liquid biopsy (xF+) and methylation assays have been valuable to Actuate’s work and how the company has benefitted from the partnership
-
03/25/2025AI & ML in action: Unlocking RWD with GenAI through Tempus Lens
Discover how Tempus is equipping researchers with innovative AI solutions to fully leverage the potential of multimodal data. Gain insights from a panel of leaders across healthcare and life sciences as they discuss the impact of these advanced tools on delivering insights with speed.
Watch replay
Secure your recording now. -
03/11/2025Case Report: Pharmacogenomic testing and mood stabilizers
This real-world case demonstrates how the Tempus nP pharmacogenomic test facilitated a personalized treatment approach for a patient with bipolar disorder.
Read more -
03/05/2025Evolving outcomes research: The convergence of data, technology, and collaboration
This white paper offers an in-depth examination of the evolving field of outcomes research, focusing on the integration of real-world data and advanced analytics to improve patient outcomes. In it, we discuss the current state of the industry, the challenges of data standardization and quality, and the collaborative efforts shaping the future. Download to explore innovative approaches that are transforming outcomes research and driving the development of patient-centric healthcare solutions.
Read more